Eye pressure changes after eye injections
Part of Eyes & vision, Heart & circulation clinical trials.
This study looks at how eye pressure changes right after an eye injection. It aims to help doctors better understand and manage pressure spikes after treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must be scheduled to receive an eye injection for a condition like diabetic macular edema, age-related macular degeneration, or retinal vein occlusion.
- You must not have a history of glaucoma or high eye pressure.
- You must not have had glaucoma surgery in the past.
- You must not have eye surface (cornea) disease that could affect accurate eye pressure readings.
- You must be able to cooperate during the eye pressure measurement.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks if repeated anti-VEGF eye injections, used to treat retinal diseases, can cause the upper eyelid to droop. It follows people getting their first injection in one eye and watches for eyelid changes.
This trial tests a new eye-numbing gel against the standard numbing method to see which works better for patients getting regular anti-VEGF injections in the eye.
This study compares two different eye injection treatments for diabetic macular edema (DME)—a condition where fluid builds up in the center of the retina, blurring vision. Researchers want to see how certain measures in the blood and in eye scans relate to how well each treatment works.
This trial tests whether specially trained nurses can safely give eye injections instead of doctors. It may make treatment quicker and easier for people who need regular injections for eye conditions.
This trial measures eye pressure right after an injection of a higher-dose Eylea (aflibercept 8mg) to see how it affects the eye. It may help people who need frequent anti-VEGF shots for conditions like wet AMD or diabetic eye disease.
This study looks at how the eyes of people with diabetes-related swelling in the retina change after their very first anti-VEGF injection. By measuring early changes in OCT scans, doctors hope to learn more about how well the treatment works and how to predict outcomes.
Hear when a new Diabetic Macular Edema trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.